Clinical trials
Skin Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 7 |
| Active, not recruiting | 6 |
| Terminated | 5 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma and Skin Cancer Trials Limited | 3 |
| Regeneron Pharmaceuticals | 3 |
| Bristol-Myers Squibb | 2 |
| Iovance Biotherapeutics, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| Abbott | 1 |
| Agenus Inc. | 1 |
| Ascend Biopharmaceuticals Ltd | 1 |
| Blaze Bioscience Australia Pty Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Skin Neoplasms | 35 |
| Melanoma | 23 |
| Neoplasm Metastasis | 5 |
| Neoplasms | 5 |
| Basal Cell Carcinoma | 4 |
| Lung Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Merkel Cell | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.